Cure51 is currently owned by Sofinnova Partners, through Sofinnova Digital Medicine I, since 2024.

When did Sofinnova Partners acquire Cure51?

Sofinnova Partners acquired Cure51 in 2024 (active for 2 years).

Home/Companies/HealthTech/Cure51

Cure51

HealthTech·

France·Active·2yr hold

Cure51 is a healthcare / digital health company, headquartered in France.

Entry

2024

Hold

2yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQFrance

SectorHealthcare / Digital Health

French digital health company building a global database of cancer survivors to identify biological features associated with exceptional…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Digital Medicine I

Other portfolio companies in the same fund.

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

Last updated April 2026 · Sourced from public filings